Related references
Note: Only part of the references are listed.Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia
Mariana Igoillo-Esteve et al.
JCI INSIGHT (2020)
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
Yutaka Ohsawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
A mitochondrial DNA D loop insertion detected almost exclusively in non-replicating tissues with maternal inheritance across three generations
Mehul A. Sharma et al.
MITOCHONDRION (2019)
Review of current evidence and clinical recommendations on the effects of low- carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force
Carol F. Kirkpatrick et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Qingmiao Shao et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
Olusola F. Onoviran et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)
Sodium-glucose co-transporter-2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: A nationwide population-based cohort study
Young-Gun Kim et al.
DIABETES OBESITY & METABOLISM (2018)
Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus
Rui-Fang Wang et al.
EPILEPSY RESEARCH (2018)
Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes
Roseanne O. Yeung et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency
Fady Hannah-Shmouni et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O'Neil et al.
LANCET (2018)
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
Aysegul Durak et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
Karolin Bettge et al.
DIABETES OBESITY & METABOLISM (2017)
Mitochondrial disease and endocrine dysfunction
Jasmine Chow et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
Sumit Parikh et al.
GENETICS IN MEDICINE (2017)
Liraglutide alleviates H2O2-induced retinal ganglion cells injury by inhibiting autophagy through mitochondrial pathways
Xuefei Ma et al.
PEPTIDES (2017)
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
Matteo Monami et al.
DIABETES OBESITY & METABOLISM (2017)
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Wataru Ogawa et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
Ronald M. Goldenberg et al.
CLINICAL THERAPEUTICS (2016)
Standards of Medical Care in Diabetes—2017 : Summary of Revisions
DIABETES CARE (2016)
Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathypatients
Sofia Ahola et al.
EMBO MOLECULAR MEDICINE (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes
Takaaki Murakami et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Prevalence of Nuclear and Mitochondrial DNA Mutations Related to Adult Mitochondrial Disease
Grainne S. Gorman et al.
ANNALS OF NEUROLOGY (2015)
Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Feng Sun et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutations causing mitochondrial disease: What is new and what challenges remain?
Robert N. Lightowlers et al.
SCIENCE (2015)
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
Sumit Parikh et al.
GENETICS IN MEDICINE (2015)
The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes
Amel Karaa et al.
PEDIATRIC DIABETES (2015)
Pancreatic β-cell Na+ channels control global Ca2+ signaling and oxidative metabolism by inducing Na+ and Ca2+ responses that are propagated into mitochondria
Iulia I. Nita et al.
FASEB JOURNAL (2014)
Exercise as a Therapeutic Strategy for Primary Mitochondrial Cytopathies
Mark A. Tarnopolsky
JOURNAL OF CHILD NEUROLOGY (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Endocrine disorders in mitochondrial disease
Andrew M. Schaefer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation
Ayman W. El-Hattab et al.
MOLECULAR GENETICS AND METABOLISM (2012)
The Pros and Cons of Diagnosing Diabetes With A1C
Enzo Bonora et al.
DIABETES CARE (2011)
Ketogenic diet slows down mitochondrial myopathy progression in mice
Sofia Ahola-Erkkila et al.
HUMAN MOLECULAR GENETICS (2010)
A neurological perspective on mitochondrial disease
Robert McFarland et al.
LANCET NEUROLOGY (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2009)
High Prevalence of Impaired Glucose Homeostasis and Myopathy in Asymptomatic and Oligosymptomatic 3243A>G Mitochondrial DNA Mutation-Positive Subjects
Anja Lisbeth Frederiksen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
Ethan J. Anderson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
John B. Buse et al.
LANCET (2009)
Prevalence and progression of diabetes in mitochondrial disease
R. G. Whittaker et al.
DIABETOLOGIA (2007)
Population prevalence of the MELAS A3243G mutation
Neil Manwaring et al.
MITOCHONDRION (2007)
L-arginine improves the symptoms of stroke-like episodes in MELAS
Y Koga et al.
NEUROLOGY (2005)
Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells
S Santra et al.
ANNALS OF NEUROLOGY (2004)
Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes
DE Kelley et al.
DIABETES (2002)
Defining the importance of mitochondrial gene defects in maternally inherited diabetes by sequencing the entire mitochondrial genome
ATW Choo-Kang et al.
DIABETES (2002)
Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell
P Maechler et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Share Paper
